GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1996 | 12-1995 | 09-1995 | 06-1995 | 03-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,540 | -8,890 | N/A | N/A | -750 |
| Depreciation Amortization | 370 | 1,360 | N/A | N/A | 380 |
| Other Operating Activity | 630 | 2,280 | 0 | 0 | -520 |
| Operating Cash Flow | $-540 | $-5,250 | $N/A | $N/A | $-890 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -60 | 400 | 0 | 0 | 130 |
| Investing Cash Flow | $-60 | $400 | $N/A | $N/A | $130 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 750 | 4,630 | 0 | 0 | 540 |
| Financing Cash Flow | $750 | $4,630 | $N/A | $N/A | $540 |
| Exchange Rate Effect | N/A | 6 | N/A | N/A | N/A |
| Beginning Cash Position | 720 | 930 | N/A | N/A | 930 |
| End Cash Position | 870 | 720 | N/A | N/A | 720 |
| Net Cash Flow | $140 | $-200 | $N/A | $N/A | $-210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -540 | -5,250 | N/A | N/A | -890 |
| Free Cash Flow | -540 | -5,250 | 0 | 0 | -890 |